Clinically assisted hydration in patients in the last days of life (‘CHELsea II’ trial): a cluster randomised trial

INTRODUCTION: Provision of clinically assisted hydration (CAH) at the end of life is one of the most contentious issues in medicine. The aim of the ‘CHELsea II’ trial is to evaluate CAH in patients in the last days of life. The objectives are to assess the effect of CAH on delirium, audible upper ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Andrew, Waghorn, Melanie, Roberts, Megan, Gage, Heather, Skene, Simon S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Palliative Care
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684991/
https://www.ncbi.nlm.nih.gov/pubmed/36418131
http://dx.doi.org/10.1136/bmjopen-2022-068846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684991/
https://www.ncbi.nlm.nih.gov/pubmed/36418131
http://dx.doi.org/10.1136/bmjopen-2022-068846

Ejemplares similares